Asia On The Move: J&J Appoints Janssen UK Head To Oversee Building Of Largest Pharma Plant In China
This article was originally published in PharmAsia News
Executive Summary
J&J appointed Janssen UK’s managing director to lead Xian Janssen in China, and BMS’ executive vice president for global commercial operations in Europe and China is transitioning to a new role within the company. Key personnel changes also took place in MSD-Simcere, Teva’s Japan subsidiary and RDPAC.